1122 (Qtern dapagliflozin 10 mg / saxagliptin 5 mg)
Generic Name: dapagliflozin/saxagliptin
Pill with imprint 1122 is Brown, Round and has been identified as Qtern dapagliflozin 10 mg / saxagliptin 5 mg. It is supplied by AstraZeneca Pharmaceuticals LP.
Qtern is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Qtern dapagliflozin 10 mg / saxagliptin 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for 1122
- Generic Name:
- dapagliflozin 10 mg / saxagliptin 5 mg
- Prescription only
- Drug Class:
- Antidiabetic combinations
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- AstraZeneca Pharmaceuticals LP
- National Drug Code (NDC):
More about Qtern (dapagliflozin / saxagliptin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: antidiabetic combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.